Table 4.
Parameter | Category | DSS | DMeFS | LRFS | ||||||
---|---|---|---|---|---|---|---|---|---|---|
H.R | 95% CI | p-value | H.R | 95% CI | p-value | H.R | 95% CI | p-value | ||
Stage | I-II | 1 | - | 0.023* | 1 | - | 0.121 | 1 | 0.023* | |
III-IV | 2.246 | 1.118-4.513 | 1.796 | 0.856-3.769 | 3.057 | 1.168-8.002 | ||||
GAD1 Exp. | Low Exp. | 1 | - | 0.004* | 1 | - | <0.001* | 1 | - | 0.013* |
High Exp. | 2.234 | 1.284-3.887 | 4.218 | 2.121-8.389 | 2.441 | 1.207-4.935 |
*, Statistically significant; DSS, disease-specific survival; DMeFS, distal metastasis-free Survival; LRFS, local recurrence-free survival